JIANGXI SANXIN MEDTEC CO.,LTD. Financials Jiangxi Sanxin Medtec Co.,Ltd.
Equities
300453
CNE100001ZJ1
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.98 CNY | -0.87% |
|
+1.92% | +4.59% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,749 | 1,983 | 4,618 | 4,977 | 3,425 | 3,965 |
| Enterprise Value (EV) 1 | 1,749 | 1,985 | 4,523 | 4,768 | 3,193 | 3,805 |
| P/E ratio | 42.4 x | 32.8 x | 40.9 x | 32 x | 18.5 x | 19.2 x |
| Yield | 0.91% | 1.32% | 1.14% | 1.19% | 1.74% | 1.51% |
| Capitalization / Revenue | 3.29 x | 2.75 x | 4.91 x | 4.27 x | 2.56 x | 3.05 x |
| EV / Revenue | 3.29 x | 2.75 x | 4.81 x | 4.1 x | 2.39 x | 2.93 x |
| EV / EBITDA | 24.9 x | 18.4 x | 24.3 x | 19.7 x | 12 x | 13 x |
| EV / FCF | -21 x | 76.4 x | 71.3 x | 67.8 x | 50.7 x | -48.3 x |
| FCF Yield | -4.77% | 1.31% | 1.4% | 1.48% | 1.97% | -2.07% |
| Price to Book | 2.97 x | 2.96 x | 5.88 x | 5.5 x | 3.18 x | 3.18 x |
| Nbr of stocks (in thousands) | 495,206 | 512,275 | 512,236 | 512,236 | 516,587 | 519,597 |
| Reference price 2 | 3.532 | 3.872 | 9.015 | 9.715 | 6.631 | 7.630 |
| Announcement Date | 3/15/19 | 3/27/20 | 3/26/21 | 3/16/22 | 3/22/23 | 3/22/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 531.3 | 721.7 | 940.4 | 1,164 | 1,336 | 1,300 |
| EBITDA 1 | 70.31 | 107.9 | 186.2 | 242.5 | 266.5 | 293.3 |
| EBIT 1 | 41.63 | 73.12 | 136.9 | 187 | 203.9 | 220.9 |
| Operating Margin | 7.84% | 10.13% | 14.56% | 16.06% | 15.26% | 16.99% |
| Earnings before Tax (EBT) 1 | 48.2 | 76.32 | 153.7 | 195.4 | 225.6 | 252.8 |
| Net income 1 | 41.15 | 61.68 | 115.6 | 155.9 | 184.6 | 206.6 |
| Net margin | 7.74% | 8.55% | 12.3% | 13.39% | 13.82% | 15.89% |
| EPS 2 | 0.0833 | 0.1179 | 0.2205 | 0.3038 | 0.3581 | 0.3984 |
| Free Cash Flow 1 | -83.44 | 25.99 | 63.46 | 70.35 | 62.94 | -78.7 |
| FCF margin | -15.71% | 3.6% | 6.75% | 6.04% | 4.71% | -6.05% |
| FCF Conversion (EBITDA) | - | 24.08% | 34.08% | 29.01% | 23.61% | - |
| FCF Conversion (Net income) | - | 42.14% | 54.88% | 45.12% | 34.09% | - |
| Dividend per Share 2 | 0.0321 | 0.0513 | 0.1026 | 0.1154 | 0.1154 | 0.1154 |
| Announcement Date | 3/15/19 | 3/27/20 | 3/26/21 | 3/16/22 | 3/22/23 | 3/22/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.02 | 1.73 | - | - | - | - |
| Net Cash position 1 | - | - | 94.6 | 209 | 232 | 160 |
| Leverage (Debt/EBITDA) | 0.000265 x | 0.016 x | - | - | - | - |
| Free Cash Flow 1 | -83.4 | 26 | 63.5 | 70.4 | 62.9 | -78.7 |
| ROE (net income / shareholders' equity) | 6.86% | 10% | 16.5% | 18.8% | 18.7% | 17.9% |
| ROA (Net income/ Total Assets) | 3.47% | 4.63% | 7.16% | 8.82% | 7.98% | 7.23% |
| Assets 1 | 1,184 | 1,332 | 1,615 | 1,768 | 2,313 | 2,857 |
| Book Value Per Share 2 | 1.190 | 1.310 | 1.530 | 1.770 | 2.080 | 2.400 |
| Cash Flow per Share 2 | 0.1600 | 0.2200 | 0.1900 | 0.4900 | 0.6200 | 0.4300 |
| Capex 1 | 132 | 123 | 98.1 | 175 | 211 | 287 |
| Capex / Sales | 24.93% | 17.05% | 10.44% | 15.01% | 15.76% | 22.11% |
| Announcement Date | 3/15/19 | 3/27/20 | 3/26/21 | 3/16/22 | 3/22/23 | 3/22/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +4.59% | 565M | |
| -4.66% | 183B | |
| -1.01% | 108B | |
| -4.20% | 67.51B | |
| +2.68% | 50.67B | |
| +9.12% | 44.7B | |
| +2.41% | 40.95B | |
| +4.13% | 26.71B | |
| +3.31% | 26.8B | |
| +12.66% | 24.62B |
- Stock Market
- Equities
- 300453 Stock
- Financials Jiangxi Sanxin Medtec Co.,Ltd.